25P Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping
Year: 2022
Type: article
Source: Annals of Oncology
Authors: J.C-H. Yang, M-J. Ahn, H. Sakai, M. Morise, T. Kato, Y-M. Chen, J-Y. Han, J-J. Yang, J. Zhao, J. Huang, K. Berghoff, R. Bruns, G. Otto, X. Le, P. Paik
Institutions: Guangdong General Hospital, National Taiwan University Hospital, Guangdong Academy of Medical Sciences, Samsung Medical Center, Sungkyunkwan University, Saitama Cancer Center, Nagoya University, Kanagawa Cancer Center, Taipei Veterans General Hospital, National Yang Ming University, National Cancer Center, Peking University Cancer Hospital, Merck Healthcare KGaA, Darmstadt (Germany), The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4226182227